NCT05367479View on ClinicalTrials.gov

Antibiotics, Gastric Bypass, and the Microbiome

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 18, 2018

Primary Completion Date

January 9, 2020

Study Completion Date

January 9, 2020

Conditions
Obesity, MorbidHypertensionBariatric Surgery Candidate
Interventions
DRUG

Antibiotic

Peri-operative, intravenous antibiotic for surgical site infection

Trial Locations (1)

53226

Froedtert Hospital, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT05367479 - Antibiotics, Gastric Bypass, and the Microbiome | Biotech Hunter | Biotech Hunter